RETACRIT FDA approval date

The FDA approved RETACRIT on 15 May 2018.

FDA approval date
15 May 2018

Drug identity has not yet been verified against registry records

Also recorded as EPOETIN ALFA-EPBX

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2018-05-15DayRETACRITFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125545", "applicant_as_listed_by_fda": "HOSPIRA INC", "brand_names": ["RETACRIT"], "active_ingredients": ["EPOETIN ALFA-EPBX"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20180515", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026